A Relative Strength Rating upgrade for Chesapeake Utilities shows improving technical performance. Will it continue?

The biomarker assay can be used potentially to enrich clinical trials and monitor patients' disease activity and treatment response.

A randomized controlled trial finds no clear benefit of adding bezlotoxumab to FMT in patients with IBD and recurrent C difficile infection.

Google stock has gained 28% in 2024 but shares have ping-ponged since July amid fierce AI competition and antitrust worries.

Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients ...

Aeglea Biotherapeutics Inc. ( (SYRE) ) has released its Q3 earnings. Here is a breakdown of the information Aeglea Biotherapeutics Inc.

Direct costs associated with IBD include ambulatory visits to gastroenterologists, emergency department visits, admissions ...

New research from ACG 2024 reveals that primary sclerosing cholangitis raises colorectal cancer risk even in patients without ...

Abu Dhabi, UAE: Sheikh Shakhbout Medical City (SSMC), one of the UAE’s largest hospitals for serious and complex care and a ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

The study identifies links between gut microbiota, genetic variants in IBD, and mental health disorders, offering insights ...

Alcohol can worsen Crohn’s disease symptoms, but the impact varies from person to person. It may depend on what and how much ...